News

AZ proposes US price cut options as CEO Pascal Soriot sides with global 'rebalancing of pricing'
With its latest $50 billion U.S. manufacturing investment and record U.S. growth, is British AstraZeneca looking at itself as an American company? | AstraZeneca CEO Pascal Soriot said the company has had many talks with the U.
Astra CEO Breaks With Peers on Aligning Drug Prices Globally
AstraZeneca Plc’s chief executive officer broke ranks with his pharmaceutical industry peers Tuesday, saying he was open to making sure Americans pay similar prices for newly developed drugs as people in other wealthy countries.
Healthy Returns: AstraZeneca CEO proposes some U.S. drug price cuts amid Trump pressure
AstraZeneca’s CEO said the company has proposed U.S. price cuts to some drugs, while Doximity enters competitive AI scribing market with new free offering.
AstraZeneca seeks US drug price cuts amid expansion plans, strong demand
AstraZeneca has proposed price cuts to its drugs in the United States, its CEO said on Tuesday, days after unveiling a $50 billion investment to expand there, as President Donald Trump pressures pharmaceuticals companies to lower costs.
AstraZeneca CEO Says World ‘Needs to Share’ in Global Pharma R&D
Pascal Soriot's comments came during AstraZeneca's Q2 earnings call in regard to President Donald Trump’s newly announced European pharma tariffs. The company also announced estimate-beating earnings,
AstraZeneca CEO Calls US Drug Pricing Model ‘Unsustainable’ — Pushes for Global Rate Alignment
AstraZeneca CEO Pascal Soriot said it’s time for the U.S. to start paying more reasonable prices for new drugs, which are closer to what other wealthy countries pay, in a rare stance in an industry that has long resisted such a shift.
AstraZeneca CEO Pascal Soriot on why he’s building in the U.S.: ‘Europe is losing ground’
That’s how long it took from the time AstraZeneca CEO Pascal Soriot greeted Virginia Governor Glenn Youngkin in his London ...
AstraZeneca CEO doubles down on U.S. amid rumors of listing shift
AstraZeneca CEO Pascal Soriot said the U.K.-listed company had many reasons to be in the U.S., adding that it was “rapidly ...
AstraZeneca increasing focus on US market, as it is 'first to provide access to patients': CFO
AstraZeneca CFO Aradhana Sarin tells Yahoo Finance the company sees US innovation threatened by China, even as it commits $50 billion in manufacturing.
FiercePharma2y
AZ's CEO Pascal Soriot fights investor skepticism—yet again
Soriot’s latest remarks came as the CEO trumpeted a “very encouraging” start to 2023. The drugmaker delivered total revenues of around $10.9 billion over the first three months of the year ...
Benzinga.com10mon
AstraZeneca CEO Pascal Soriot Updates On Chinese Compliance ... - Benzinga
CEO Pascal Soriot said AstraZeneca is compliant with Chinese policies and is working closely with authorities following the detention. Historic Summer Setup: 3 "Power Patterns" Triggering in the ...
Fox Business4y
AstraZeneca's Pascal Soriot says researchers believe shot will be ...
AstraZeneca chief executive Pascal Soriot also told the Sunday Times that researchers developing its vaccine have figured out a “winning formula” making the jab as effective as rival candidates.
Forbes12y
Can Pascal Soriot Turn Around AstraZeneca? It May Come Down To ... - Forbes
This morning in New York, new AstraZeneca chief executive Pascal Soriot is telling investors how he is going to turn around the company that has had the absolute worst track record in research and ...
We are very American now, says Astra boss: Soriot fuels fears of switch to New York
Speaking from Astra's offices in New York, Sir Pascal Soriot (pictured) said it was 'global', but it was 'very much rooted ...